Suppr超能文献

当代慢性病临床决策支持系统的设计、效果和经济结果:系统评价和荟萃分析。

Design, effectiveness, and economic outcomes of contemporary chronic disease clinical decision support systems: a systematic review and meta-analysis.

机构信息

Menzies School of Health Research, Charles Darwin University, Casuarina, Northern Territory, Australia.

School of Public Health, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.

出版信息

J Am Med Inform Assoc. 2022 Sep 12;29(10):1757-1772. doi: 10.1093/jamia/ocac110.

Abstract

OBJECTIVES

Electronic health record-based clinical decision support (CDS) has the potential to improve health outcomes. This systematic review investigates the design, effectiveness, and economic outcomes of CDS targeting several common chronic diseases.

MATERIAL AND METHODS

We conducted a search in PubMed (Medline), EBSCOHOST (CINAHL, APA PsychInfo, EconLit), and Web of Science. We limited the search to studies from 2011 to 2021. Studies were included if the CDS was electronic health record-based and targeted one or more of the following chronic diseases: cardiovascular disease, diabetes, chronic kidney disease, hypertension, and hypercholesterolemia. Studies with effectiveness or economic outcomes were considered for inclusion, and a meta-analysis was conducted.

RESULTS

The review included 76 studies with effectiveness outcomes and 9 with economic outcomes. Of the effectiveness studies, 63% described a positive outcome that favored the CDS intervention group. However, meta-analysis demonstrated that effect sizes were heterogenous and small, with limited clinical and statistical significance. Of the economic studies, most full economic evaluations (n = 5) used a modeled analysis approach. Cost-effectiveness of CDS varied widely between studies, with an estimated incremental cost-effectiveness ratio ranging between USD$2192 to USD$151 955 per QALY.

CONCLUSION

We summarize contemporary chronic disease CDS designs and evaluation results. The effectiveness and cost-effectiveness results for CDS interventions are highly heterogeneous, likely due to differences in implementation context and evaluation methodology. Improved quality of reporting, particularly from modeled economic evaluations, would assist decision makers to better interpret and utilize results from these primary research studies.

REGISTRATION

PROSPERO (CRD42020203716).

摘要

目的

基于电子健康记录的临床决策支持(CDS)有可能改善健康结果。本系统评价调查了针对几种常见慢性病的 CDS 的设计、效果和经济结果。

材料和方法

我们在 PubMed(医学文献在线数据库)、EBSCOHOST(CINAHL、APA PsychInfo、EconLit)和 Web of Science 中进行了搜索。我们将搜索范围限制在 2011 年至 2021 年的研究。如果 CDS 基于电子健康记录且针对以下一种或多种慢性病:心血管疾病、糖尿病、慢性肾脏病、高血压和高胆固醇血症,则纳入研究。考虑纳入具有效果或经济结果的研究,并进行了荟萃分析。

结果

本综述纳入了 76 项具有效果结果的研究和 9 项具有经济结果的研究。在有效性研究中,63%描述了有利于 CDS 干预组的积极结果。然而,荟萃分析表明,效应大小存在异质性且较小,具有有限的临床和统计学意义。在经济研究中,大多数完整的经济评估(n=5)使用了模型分析方法。CDS 的成本效益在研究之间差异很大,估计的增量成本效益比在每 QALY 2192 美元至 151955 美元之间。

结论

我们总结了当代慢性疾病 CDS 的设计和评估结果。CDS 干预措施的有效性和成本效益结果高度异质,这可能是由于实施背景和评估方法的差异所致。改善报告质量,特别是来自模型经济评估的报告质量,将有助于决策者更好地解释和利用这些原始研究的结果。

登记号

PROSPERO(CRD42020203716)。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a890/9471723/98445ce01e31/ocac110f1.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验